KIR3DL2/CD158k Antibody (539304) [Janelia Fluor® 585]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2878JF585
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 585
Antibody Source
Monoclonal Mouse IgG1 Clone # 539304
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
BaF3 mouse pro-B cell line transfected with human KIR3DL2/CD158k
Accession # P43630
Accession # P43630
Specificity
Detects human KIR3DL2/CD158k in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for KIR3DL2/CD158k Antibody (539304) [Janelia Fluor® 585]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: KIR3DL2/CD158k
Long Name
Killer Cell Immunoglobulin-like Receptor, Three Domain Long Cytoplasmic Tail, 2
Alternate Names
CD158k, CL-5, NKAT4A, NKAT4B
Gene Symbol
KIR3DL2
Additional KIR3DL2/CD158k Products
Product Documents for KIR3DL2/CD158k Antibody (539304) [Janelia Fluor® 585]
Product Specific Notices for KIR3DL2/CD158k Antibody (539304) [Janelia Fluor® 585]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...